enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.52M | 11.58M | 11.69M | 10.93M | 10.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.28M | 23.83M | 23.41M | 22.58M | 23.94M |
| Operating Income | -23.28M | -23.83M | -23.41M | -22.58M | -23.94M |
| Income Before Tax | -21.33M | -21.82M | -21.24M | -20.60M | -22.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.33 | -21.82 | -21.24 | -20.60 | -22.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.33M | -21.82M | -21.24M | -20.60M | -22.12M |
| EBIT | -23.28M | -23.83M | -23.41M | -22.58M | -23.94M |
| EBITDA | -23.10M | -23.64M | -23.20M | -22.37M | -23.72M |
| EPS Basic | -1.25 | -1.34 | -1.40 | -1.49 | -1.80 |
| Normalized Basic EPS | -0.83 | -0.90 | -0.95 | -1.01 | -1.21 |
| EPS Diluted | -1.25 | -1.34 | -1.40 | -1.49 | -1.80 |
| Normalized Diluted EPS | -0.83 | -0.90 | -0.95 | -1.01 | -1.21 |
| Average Basic Shares Outstanding | 70.13M | 65.83M | 60.97M | 56.13M | 52.27M |
| Average Diluted Shares Outstanding | 70.13M | 65.83M | 60.97M | 56.13M | 52.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |